Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Jubilant Ingrevia Completes 100% Acquisition of Remidex
Closed
HealthcarePlatform
Deal Overview
Jubilant Ingrevia has completed its 100% acquisition of Remidex Pharma Private Limited. The transaction is closed.
The provided deal information does not include financial terms, purchase price, or the specific geographic footprint of Remidex Pharma.
Key Details
- Transaction
- Jubilant Ingrevia acquires Remidex Pharma
Related Deals
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. for €7.5m to Expand EU Reach - scanx.trade
HealthcareAdd-on
Marksans Pharma→QliniQ
Jun 1, 2026
Altruix Acquired By Frazier Healthcare Partners And Randy Hyun Appointed CEO - Pulse 2.0
HealthcareOther
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
HealthcareOther
Signos
May 31, 2026
Sterling Bay Partnership Secures $290M Financing for Sorrento Mesa’s Pacific Center
HealthcareCaliforniaOther
Sterling Bay→Pacific Center
May 29, 2026